Rich countries are opening up societies and vaccinating young people who are not at great risk from Covid-19, while the poorest countries cruelly lack doses, the World Health Organization said on ...

As the country scrambles to curb the spread of Covid-19, we will be entering yet another lockdown. The current infection rate stands at 23.86 percent, with specific regions crumbling under surmounting ...

As we head into the 2026, let's take a look at biotech licensing deals and M&As that were inked in December 2025.

With COVID sales falling and patent protections expiring, Pfizer is forecasting its 2026 revenue to be in the range of $59.5 billion to $62.5 billion. The midpoint of the projection ($61 billion) ...

SHANGHAI, CHINA - 2025/11/08: The Pfizer logo is presented at the 8th China International Import Expo. (Photo by Sheldon Cooper/SOPA Images/LightRocket via Getty Images) Pfizer (PFE) is encountering ...

Pfizer sees $1.5 billion revenue drop from COVID products next year Pfizer's 2026 R&D expenses rise due to antibody development and clinical programs Pfizer's 2025 revenue forecast revised to about ...

After beefing up the target of its global cost-savings drive once again, Pfizer is continuing to see its plan through with cuts in numerous countries. Now, hundreds of employees in Switzerland are due ...

This year’s flu season is shaping up to be a nasty one—driven by a new variant of the influenza virus that may be able to slip past our vaccine defenses. A mutated form of the influenza A strain H3N2 ...

As 2025 closes out, a pair of autoimmune biotechs have eked out separate deals with Big Pharma before year-end, each with a sizable potential payout down the line. Seattle’s Adaptive Biotechnologies, ...

Here’s what to know about the dominant version of the virus that’s circulating now. By Dani Blum The flu constantly morphs and mutates. Often, it surprises researchers a little. This year, the virus ...

Flu season is among us, and a new strain has emerged as a major threat. A mutation of influenza A H3N2, called subclade K, has been detected as the culprit in rising global cases, including in the U.S ...

Flu season in America is underway with a new variant called subclade K, recent Centers for Disease Control and Prevention (CDC) data shows. In the week ending December 6, the first full week after ...